NYSE:HYH

Halyard Health (HYH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$56.93
$57.91
50-Day Range
N/A
52-Week Range
$38.22
$61.52
Volume
886,271 shs
Average Volume
438,537 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HYH stock logo

About Halyard Health Stock (NYSE:HYH)

Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm's portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.

HYH Stock News Headlines

HALYARD PRINCIPALS LLC's Net Worth
Health Care
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Avanos Medical Inc (AVNS)
Exposed: 10 CENT Crypto to Explode April 20th?
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Halyard Health Announces New Drainage System, Stock Down
See More Headlines
Receive HYH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Halyard Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2017
Today
4/27/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Joseph F. Woody
    Chief Executive Officer & Executive Director
  • Michael C. Greiner
    Chief Financial Officer & Senior Vice President
  • Lee Burnes
    Senior VP-Global Research & Development
  • Michelle Scharfenberg
    Senior VP, Chief Ethics & Compliance Officer
  • Rhonda D. Gibby
    Chief Human Resources Officer & Senior VP

HYH Stock Analysis - Frequently Asked Questions

How were Halyard Health's earnings last quarter?

Halyard Health, Inc. (NYSE:HYH) announced its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.13. The medical instruments supplier earned $401.40 million during the quarter, compared to the consensus estimate of $394.54 million. The business's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.48 earnings per share.

What other stocks do shareholders of Halyard Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Halyard Health investors own include Kimberly-Clark (KMB), Allergan (AGN), Cisco Systems (CSCO), General Electric (GE), Kinder Morgan (KMI), Gilead Sciences (GILD), Intel (INTC), Ionis Pharmaceuticals (IONS) and Johnson & Johnson (JNJ).

This page (NYSE:HYH) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners